[HTML][HTML] Biomimetic nanotechnology for SARS-CoV-2 treatment
More than 600 million people worldwide have been infected with severe acute respiratory
syndrome coronavirus 2 (SARS-CoV-2), resulting in the pandemic of coronavirus disease …
syndrome coronavirus 2 (SARS-CoV-2), resulting in the pandemic of coronavirus disease …
Dissecting the intricacies of human antibody responses to SARS-CoV-1 and SARS-CoV-2 infection
R Wang, Y Han, R Zhang, J Zhu, X Nan, Y Liu, Z Yang… - Immunity, 2023 - cell.com
The 2003 severe acute respiratory syndrome coronavirus (SARS-CoV-1) causes more
severe disease than SARS-CoV-2, which is responsible for COVID-19. However, our …
severe disease than SARS-CoV-2, which is responsible for COVID-19. However, our …
[HTML][HTML] Aerosol Inhalation of Chimpanzee Adenovirus Vectors (ChAd68) Expressing Ancestral or Omicron BA. 1 Stabilized Pre–Fusion Spike Glycoproteins Protects …
S Wang, M Qin, L Xu, T Mu, P Zhao, B Sun, Y Wu… - Vaccines, 2023 - mdpi.com
Current COVID-19 vaccines are effective countermeasures to control the SARS-CoV-2 virus
pandemic by inducing systemic immune responses through intramuscular injection …
pandemic by inducing systemic immune responses through intramuscular injection …
[HTML][HTML] CoV2-TCR: A web server for screening TCR CDR3 from TCR immune repertoire of COVID-19 patients and their recognized SARS-CoV-2 epitopes
X Jian, Y Zhang, J Zhao, Z Zhao, M Lu, L Xie - Computational and Structural …, 2023 - Elsevier
Although multiple vaccines have been developed and widely administered, several severe
acute respiratory syndrome coronavirus 2 (SARS-CoV-2) variants have been reported to …
acute respiratory syndrome coronavirus 2 (SARS-CoV-2) variants have been reported to …
[HTML][HTML] NGS implementation for monitoring SARS-CoV-2 variants in Chicagoland: An institutional perspective, successes and challenges
AC Tartanian, N Mulroney, K Poselenzny… - Frontiers in Public …, 2023 - frontiersin.org
Identification of SARS-CoV-2 lineages has shown to provide invaluable information
regarding treatment efficacy, viral transmissibility, disease severity, and immune evasion …
regarding treatment efficacy, viral transmissibility, disease severity, and immune evasion …
Diminished Neutralization Capacity of SARS-CoV-2 Omicron BA. 1 in Donor Plasma Collected from January to March 2021
YCJ Lin, DH Evans, NF Robbins, G Orjuela… - Microbiology …, 2023 - Am Soc Microbiol
The 50% plaque reduction neutralization assay (PRNT50) has been previously used to
assess the neutralization capacity of donor plasma against wild-type and variant of concern …
assess the neutralization capacity of donor plasma against wild-type and variant of concern …
[HTML][HTML] Navigating Vaccine Uncertainty: Anxiety and Fourth Dose Hesitancy Among Saudi Adults
MM Althomali, AS Almalki, SM Alotaibi, AM Alsalman… - Cureus, 2023 - ncbi.nlm.nih.gov
Background The continuous evolution of new variants of severe acute respiratory syndrome
coronavirus 2 (SARS-CoV-2) and early evidence of declining effectiveness of the third dose …
coronavirus 2 (SARS-CoV-2) and early evidence of declining effectiveness of the third dose …
[PDF][PDF] Immune response–genesis, duration, and strength in patients with moderate and severe coronavirus infection of different age groups
P Atanasov, M Moneva-Sakelarieva… - …, 2023 - pharmacia.pensoft.net
Acquired (adaptive) immunity is a major factor determining effective immune response
against a few infectious diseases. The immune response during recovery from COVID-19 is …
against a few infectious diseases. The immune response during recovery from COVID-19 is …
[HTML][HTML] Breakthrough infection with Omicron subvariant BF. 7 induces broadly neutralizing antibodies to SARS-CoV-2 variants including XBB lineage
L Zhang, Q Zhang, P Chen, Z Yang, Q Lv, H Wang… - 2023 - europepmc.org
Since China eased its COVID-19 response strategies in late 2022, we have been witnessing
a rapid and wide spread of SARS-CoV-2 infection across the major cities, including capital …
a rapid and wide spread of SARS-CoV-2 infection across the major cities, including capital …
[引用][C] Biomimetic Nanotechnology for SARS-CoV-2 Treatment. Viruses 2023, 15, 596
S Li, X Liu, G Liu, C Liu - 2023 - europepmc.org
More than 600 million people worldwide have been infected with severe acute respiratory
syndrome coronavirus 2 (SARS-CoV-2), resulting in the pandemic of coronavirus disease …
syndrome coronavirus 2 (SARS-CoV-2), resulting in the pandemic of coronavirus disease …